Topic: AD

Gait dysfunction in AD: clinical and anatomical correlates

February 27, 2013  

Pilot study of GSK-3 drug tested in AD

February 13, 2013  

Pilot study of GSK-3 drug tested in AD

December 26, 2012  

Mortality risk doubled in AD patients

December 5, 2012  

The woes of neurology drug development: Eli Lilly

November 21, 2012  

Testing the new NIA-AA criteria for MCI

November 21, 2012  

AD patients at high risk of falls

May 16, 2012  

What is a relevant change in ADAS-cog?

April 11, 2012  

Nicotine produces benefits in MCI

March 14, 2012  

Valproate: no benefit for clinical progression in AD

February 22, 2012